Drugs / Magnesium SO4
Magnesium SO4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03322878 | Nov → Dec 2017 | — | Cairo University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Magnesium SO4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03322878 ↗ |
| Known as | magnesium sulphate | “Group IV (n=30) will receive intravenous (IV) 20 ml magnesium SO4 (50 mg/ kg 10% MgSO4(magnesium sulphate) diluted in normal saline to a total volume of 20 ml(milliliter) ) and...” NCT03322878 ↗ |
| Known as | MgSO4 | “Group IV (n=30) will receive intravenous (IV) 20 ml magnesium SO4 (50 mg/ kg 10% MgSO4(magnesium sulphate) diluted in normal saline to a total volume of 20 ml(milliliter) ) and...” NCT03322878 ↗ |
| Route | Intravenous | “intravenous magnesium sulfate” NCT03322878 ↗ |